Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Index levels are a useful barometer for market strength. This intro explains what index levels represent and how you can read them to inform your analysis.
27,688 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
The White House has tapped a real-estate heir as acting director of national intelligence, a move that drew sharp que...
A 62-year-old diagnosed with serious illness chooses to take Social Security now rather than wait until 70, highlight...
Ark Invest discloses a fresh Palantir stake as AI momentum collides with higher yields, prompting debate over whether...
Agentic AI changes how data centers think and act. This guide breaks down AMD, ARM, and Intel to identify the intel: ...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
A stock that has surged 1,000% in a year can still offer opportunity — if you know where to look. This guide breaks d...
Nu Holdings stands at a pivotal moment in 2026. This piece breaks down three catalysts that could send Nu stock soari...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...